Biomarkers in Patients Undergoing Atrial Fibrillation Ablation
NCT ID: NCT03388333
Last Updated: 2019-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2017-01-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT02208102
The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT01148914
Atrial Fibrillation Management in Congestive Heart Failure With Ablation
NCT00652522
Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)
NCT04761315
Atrial Fibrillation Ablation
NCT03410966
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atrial fibrillation ablation group
Patients undergoing catheter ablation for the treatment of atrial fibrillation.
Catheter Ablation
Electrophysiological study group
Patients undergoing a diagnostic electrophysiological study without ablation.
No interventions assigned to this group
Atrial flutter ablation group
Patients undergoing catheter ablation of right atrial flutter at the cavotricuspid isthmus.
Catheter Ablation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Catheter Ablation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients scheduled for an electrophysiological study without ablation
* patients with a catheter ablation at the cavotricuspid isthmus for the treatment of right atrial flutter
Exclusion Criteria
* Acute myocardial infarction, coronary artery bypass graft surgery or open heart surgery within less than 3 months prior to inclusion
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Christian Meyer
Prof. Dr. Christian Meyer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Meyer, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Germany Department of Cardiology - Electrophysiology, University Heart Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiology - Electrophysiology, University Heart Centre, University Hospital Hamburg-Eppendorf
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D4/17-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.